A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HRU / healthcare resource utilization

[Related PubMed/MEDLINE]
Total Number of Papers: 154
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HRU  (>> Co-occurring Abbreviation)
Long Form:   healthcare resource utilization
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome. CS, FACT-G, PROMIS, QOL, SSAs
2019 Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005-2014. CI, HZ, IC, IR, PY, SD
2019 Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis. allo-HCT, GI, GVHD
2019 Clinical Outcomes, Treatment Patterns, and Health Resource Utilization Among Metastatic Breast Cancer Patients with Germline BRCA1/2 Mutation: AReal-World Retrospective Study. MBC, OS, TNBC
2019 Cost of osteoporotic hip fracture in Spain per Autonomous Region. OHF
2019 Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China. AE, ALL, AML, CEA, ICERs, NHL, PSA, QALY, SOC, TLS
2019 Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. CKD, DD, ESAs, Hb, HRQoL, SLR
2019 Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States. aOR, ER, IP, IRR, OP, SSc
2019 Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. CKD, ESAs, HRQoL, NDD
10  2019 Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis. ER, ILD, IP, IRRs, ORs, SSc
11  2019 Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England. HK
12  2019 Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review. DM, QOL, SH, SLR, T1DM, T2DM
13  2019 Frailty and Greater Health Care Resource Utilization Following Major Urologic Oncology Surgery. CI
14  2019 Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan. CD, HRQoL, IBD, MCS, PCS, SF-6D, UC
15  2019 Healthcare utilization and costs among relapsed or refractory multiple myeloma patients on carfilzomib or pomalidomide as monotherapy or in combination with dexamethasone. IPTW, LOT, MM, STC
16  2019 Impact of adding a video to patient education on quality of life among adults with atrial fibrillation: a randomized controlled trial. AF, QOL
17  2019 Implementing an interstitial lung disease clinic improves survival without increasing health care resource utilization. ILD
18  2019 Incident gout and chronic Kidney Disease: healthcare utilization and survival. CHS, CKD
19  2019 Medicaid spending burden among beneficiaries with treatment-resistant depression. CDs, IRRs, MDD, TRD
20  2019 Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. APs, MMCD, OR
21  2019 Short-term costs associated with non-medical switching in autoimmune conditions. NMS
22  2019 Smoking Status and Cost of Illness in Patients with Depressive Disorder Based on the National Health Survey in Spain. DD, LWDE, NHS
23  2019 The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders. EPS, TD
24  2019 Treatment patterns and healthcare resource utilization in patients with FLT3-mutated and wild-type acute myeloid leukemia: A medical chart study. AML, FLT3-WT, FLT3mut, ND, R/R
25  2019 Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings. BRCA, HER2, HP, MBC, OS, PFS, TN, TNBC
26  2018 A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation. DOACs, LOS, NVAF, RWE
27  2018 Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate. APs
28  2018 Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics. AP, LAI, OM, PDC, TM
29  2018 Association of obesity with healthcare resource utilization and costs in a commercial population. BMI
30  2018 Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States. CML, IP, TKI
31  2018 CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource Utilization. EGFR, WBRT
32  2018 Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population. DoD, PsA, PSM, PsO
33  2018 Deriving common comorbidity indices from the MedDRA classification and exploring their performance on key outcomes in patients with rheumatoid arthritis. CDI, FCI, MedDRA, RDCI
34  2018 Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database. MDD, PPPY, TRD
35  2018 Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study. SLE
36  2018 Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma. DLBCL, HSCT
37  2018 Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database. ED, MM, PPPY, SREs
38  2018 Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States. CIU
39  2018 Health Care Resource Utilization Among Children With Congenital Heart Disease: A Population-Based Study. CHD, SV
40  2018 Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans. PP3M, VHA
41  2018 Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study. MM, RB, SB, SCC, SD, SD
42  2018 Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy. AEs
43  2018 Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy. MM, PPY
44  2018 Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant. ED, FS, HCCs, SD, TDM, VS
45  2018 Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study. SD, SREs
46  2018 Impact of coexisting overactive bladder in Medicare patients with osteoporosis. OAB
47  2018 Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS. ART, PLHIV
48  2018 National Prevalence of Poor Asthma Control and Associated Outcomes Among School-Aged Children in the United States. AS, ED, IP, SABA, SAC
49  2018 Palliative Care and Hospice Interventions in Decompensated Cirrhosis and Hepatocellular Carcinoma: A Rapid Review of Literature. DC, EOLC, HCC, PC
50  2018 Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database. HNC
51  2018 Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. HRQoL, MHDs, NHWS, SF-36v2, SF-6D, WPAI
52  2018 Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma. PPPM
53  2018 Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data. aRCC, RCC, TOT
54  2018 Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in Quebec. FGA-LAI, LAI-AP, OAP, SCZ, SGA-LAI
55  2018 Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States. SD
56  2018 Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease. CD, CI, ES, IBD, UC
57  2018 The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017. OUD
58  2018 Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis. mCRPC
59  2018 Treatment patterns, clinical and economic outcomes of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer receiving ceritinib: a retrospective observational claims analysis. ALK, NSCLC
60  2018 Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States. CIU/CSU, IRR, MCD, PPPY
61  2018 Understanding healthcare burden and treatment patterns among young adults with schizophrenia. aIRR, CI, LOS, PPPY
62  2017 A Retrospective Cohort Study of the Incidence, Healthcare Resource Utilization, and Costs of ICD-9 Diagnosed Influenza and Related Complications in US Children. ---
63  2017 Association of obesity with healthcare utilization and costs in a Medicare population. BMI, MA, ObI, ObII, ObIII, OW
64  2017 Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting. PDC
65  2017 Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study. QOL
66  2017 Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis. OS, RCC
67  2017 Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany. ADHD, ATX, LA-MPH
68  2017 Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis. PPPM, RA, RCI, SLE
69  2017 Effect of late prophylaxis in hemophilia on joint status: a randomized trial. BEs, CAJAS, EQ-5D-3L, HRQoL, LS, MRI, OD
70  2017 Global health resource utilization associated with pacemaker complications. DVT, EPs
71  2017 Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency. ASCO, ASH, CML, ER, MPR, TKIs
72  2017 Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study. LOS, SREs
73  2017 Healthcare Resource Utilization Associated with Burns and Necrotizing Fasciitis: A Single-Center Comparative Analysis. LOS, NF
74  2017 Healthcare resource utilization, healthcare costs and dose escalation in psoriasis patients initiated on ustekinumab versus adalimumab: a retrospective claim study. pp
75  2017 Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases. BPI-SF, CRPC, ES, FACT-P, HRQoL, IRR, SSEs
76  2017 Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden. PD, PDP, QOL
77  2017 Real-world health care utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir HFA) with and without integrated dose counters. CI, ED, HFA, IDCs, OR
78  2017 The Burden of Chronic Urticaria from Brazilian Patients' Perspective. CU, CU, HRQoL
79  2017 The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status. EQ-5D-5L, HRQoL
80  2017 Treatment patterns and healthcare costs among newly-diagnosed patients with chronic myeloid leukemia receiving dasatinib or nilotinib as first-line therapy in the United States. CML, HR, IRR, PDC, TKI
81  2017 Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics. IRR, MMCD, OAAs, OR, PDC, PP-LAI, SGA-LAIs
82  2016 Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone. ER, IR, PPPM
83  2016 Cognitive status is a determinant of health resource utilization among individuals with a history of falls: a 12-month prospective cohort study. MCI, MoCA
84  2016 Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis. AE, IRR, MBC, PPPM
85  2016 Cost of skeletal complications from bone metastases in six European countries. PPP, SREs
86  2016 Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. sUA, ULT
87  2016 Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis. IRR, RA, TNFi
88  2016 Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder. ACB, AEs, OAB, PMPM, PTMPM, UTI
89  2016 Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire. ACQ-5
90  2016 Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant. HSCTs
91  2016 Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics. OAB
92  2016 Health resource utilization associated with skeletal-related events: results from a retrospective European study. SREs
93  2016 Health resource utilization varies by comorbidities in children with epilepsy. ADHD, aRR, ASD, ED
94  2016 Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12Months of Immunoglobulin G Treatment. APs, GP, HRQoL, IgG, OCC, PIDD, PP
95  2016 Healthcare resource utilization after medium-term residential assessment for epilepsy and psychogenic nonepileptic seizures. CPY, ES, MTRA, SEC
96  2016 Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate. aIRR, CI, ED, SGA-LAIs
97  2016 Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries. PF
98  2016 Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C. CI
99  2016 Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy. AE, MBC, PPPM
100  2016 The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. CDST, ED, PS